OXAPROZIN - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for oxaprozin and what is the scope of patent protection?

Oxaprozin is the generic ingredient in four branded drugs marketed by Solubiomix, Pfizer, Actavis Elizabeth, Amneal Pharms Co, Beximco Pharms Usa, Chartwell, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan Pharms Inc, Norvium Bioscience, Pangea, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for oxaprozin. Eleven suppliers are listed for this compound.

Summary for OXAPROZIN

US Patents:	0
Tradenames:	4
Applicants:	15
NDAs:	16
Drug Master File Entries:	13
Finished Product Suppliers / Packagers:	11
Raw Ingredient (Bulk) Api Vendors:	117
Clinical Trials:	3
Patent Applications:	7,401
Drug Prices:	Drug price trends for OXAPROZIN
What excipients (inactive ingredients) are in OXAPROZIN?	OXAPROZIN excipients list
DailyMed Link:	OXAPROZIN at DailyMed

See drug prices for OXAPROZIN

See drug sales revenues for OXAPROZIN

Recent Clinical Trials for OXAPROZIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mochida Pharmaceutical Company, Ltd.	Phase 1
Fuji Yakuhin Co., Ltd.	Phase 1
Federal University of São Paulo	Phase 4

See all OXAPROZIN clinical trials

Pharmacology for OXAPROZIN

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for OXAPROZIN

M01AE	Propionic acid derivatives
M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

US Patents and Regulatory Information for OXAPROZIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva	OXAPROZIN	oxaprozin	TABLET;ORAL	075849-001	Jul 3, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	DAYPRO ALTA	oxaprozin potassium	TABLET;ORAL	020776-001	Oct 17, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan Pharms Inc	OXAPROZIN	oxaprozin	TABLET;ORAL	075847-001	Feb 28, 2001		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.